Crossmark

Immune checkpoint inhibitor in third-line treatment of microsatellite stable metastatic colorectal cancer: an observational and retrospective study

Published Online: 2026-02-16

Authors

Zhao, Qinshuo

Zhao, Ke

Song, Jian

Zhao, Wensi https://orcid.org/0000-0002-0610-7701
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82102954)
License Information

Text and Data Mining valid from 2026-02-16

Version of Record valid from 2026-03-25
More Information

Article History

Received: 12 March 2025

Accepted: 11 February 2026

First Online: 16 February 2026

Declarations

:

: This study was approved by the ethics committee of Renmin Hospital of Wuhan University (No. 2023 K-K067) in accordance with the Declaration of Helsinki. All patients voluntarily participated and provided written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current